Stab gave hero hep C

2007-03-31 23:07:42

Stab gave hero hep C
By SHEENA JACKSON
Abbotsford News
May 26 2007
In 2000, Dave Woloshen risked his life to fight off a man savagely attacking a
woman in Abbotsford.
The victim was beaten and stabbed multiple times in an apartment.
Woloshen confronted the attacker and was stabbed in the back.
A frantic scuffle ensued and he managed to fight off the attacker, break free
and call for help.
The woman survived. The attacker was convicted and sentenced.
The Mission man sees the victim occasionally. He said she calls him "her
guardian angel."
Two months ago, Woloshen was diagnosed with hepatitis C, a potentially fatal
liver condition.
He was devastated by the news and believes his actions from seven years ago have
come back to haunt him in a cruel fashion.
"I saved that lady's life and all I got in return was hepatitis C."
The 31-year-old claims the only way he could have contracted the disease was
from the stabbing.
"I've only been poked by nurses and doctors. I've never used needles."
To add to his trauma, he said he is ineligible for treatment under PharmaCare
because his enzyme levels, which show the levels of liver function, don't meet
the criteria set by PharmaCare.
"My liver is functioning and my doctor says I am a prime candidate for getting
treatment. I have a 65 per cent chance of beating this."
Woloshen's situation is not isolated, according to Dr. John Farley, a specialist
in infectious diseases treating patients in Abbotsford twice a week.
Farley spoke with the Abbotsford News a fortnight ago and how it affects a
number of his patients diagnosed with hepatitis C.
"There are so many ridiculous bureacracies into getting the treatment approved
that many people who are eligible for treatment are not able to get it," he said
in an interview.
PharmaCare's eligibility criteria for hepatitis C treatment drugs such as
pegetron and Pegasys RBV is based on several factors such as the patient's level
of liver function which shows enzymes levels.
However, Farley said the criteria has been shown time and again to be
unreliable, with levels set too high.
But Ministry of Health spokesperson Sarah Plank told the News two weeks ago
PharmaCare's criteria is based on what has been shown by clinical trials and
research studies to be the most effective.
In the meantime, Woloshen said his diagnosis rehashes the stabbing incident
seven years ago but, still, he doesn't regret what he did.
"I'm just that type of person. I will go out of my way for anybody."
Woloshen is determined to beat the disease and hopes to get treatment.
"I feel not too bad, but I'm frustrated and angered I can't get the treatment I
need. If a doctor says it's needed, it's needed. It's another thing I am willing
to battle to ensure another few years of my life."
http://www.abbynews.com/portals-code/list.cgi?paper=38&cat=23&id=992388&more=0

Volunteers Look to Educate During Hepatitis Awareness Month

2007-03-31 18:35:56

Volunteers Look to Educate During Hepatitis Awareness Month
May 24, 2007 09:36 PM EST
HONOLULU (KHNL) - One of every 50 Hawaii residents carries hepatitis C.
But, less then half them actually know it.
Here in Hepatitis Awareness Month, volunteers are working hard to spread the
word on this misunderstood disease -- as their Random Act of Kindness.
More than 20,000 people in Hawaii are infected with the deadly -- hepatitis C.
That's enough to fill the Stan Sheriff Center.
Twice.
''Hepatitis is such a big thing," says volunteer Marsha Rose Joyner. "People
walk around and not know they've got it. So, it takes all of us, that you see
volunteering to make people aware of what hepatitis is, what it does to the body
and how we can affect some kind of a cure."
It turns out, many patients finally discover they it when their liver is damaged
beyond repair.
In most cases, by then, it's too late.
There is no cure for hepatitis C.
That's why educating the public is all the more crucial.
''Hawaii doesn't have a lot of money when it comes to medical care," explains
infectious disease specialist, Dr. Alan Tice. "But, we've recognized the disease
and there's a phenomenal number of people who volunteer, contributing their
efforts to try and help with this silent epidemic."
''My greatest hope is that we can reach as many people as we can, to get tested.
If you don't get tested, then you don't know," says NovaLei Gonzales, who also
lives with the deadly disease. "But, once you know, then there is help, and
there is treatment."
And with treatment comes hope.
http://www.khnl.com/Global/story.asp?S=6567260

Pics from Washington DC Hepatitis C Briefings 5/22/07

2007-03-31 13:24:35

Pics from Washington DC Hepatitis C Briefings 5/22/07
http://www.kodakgallery.com/I.jsp?c=k8kfcz3.6sofuck3&x=1&y=l7t3z1

The Hepatitis C Epidemic Control and Prevention Act FYI

2007-03-31 11:45:28

The Hepatitis C Epidemic Control and Prevention Act (SB 1445) was reintroduced
in the 110th Congress on May 22, 2007 with bi-partisan support by Senators
Edward Kennedy (D-MA) and Kay Bailey Hutchison (R-TX). The companion bill (HR
2552) was introduced May 24, 2007 with bi-partisan support by U.S. House by
Representatives Edolphus Towns (D-NY) and Heather Wilson (R- NM).

Re: My Biospy Results

2007-03-31 05:43:22

do my best to try and
get out there and do things and not let my illness or knees make me
become a
hermit..
GREAT IDEA! I'm Bayla..new to this board but not to others..hiya
Sally..hey Dennis and welcome Sir John I do belive we've met :)
Bayla

"Those Looks" by Sir John*new*

2007-03-30 20:23:26

Those Looks
Those looks I get cause I'm so sick
you know the ones I mean
The eyes that roll cause I'm too tired
or the doubting looks cause hep's unseen
Do you really think I'm faking
that I want to be this way
That I love sitting here day by day
is that what you want to say
I know you are impatient
tired of helping me
but this isn't my choice either
how I wish that I was free
Please keep those looks to youself
I've enough without your scorn
my body is all broken now
and deep down I'm forlorn
I just hope and pray you never find
what I daily have to feel
that you never know what I do
that this dragons very real...
J. W. Cutrer
05/17/07
Manager
Hep C Heppers for Awareness
http://forums.delphiforums.com/between/start
Also see Heppers for Awareness & Tales from Free Realm Blog
on

Color me GONE :-)

2007-03-30 11:22:25

Well my timing got messed up a bit and I can't leave town until tomorrow
morning........ but I will be gone for a WEEK to DC so please understand if I
owe you an email or don't answer one you send this week. I don't have computer
access when I travel. Take care of each other and I will be back on here next
Saturday.
Peace
Pam
PS - For those that have been keeping up with my friend Ron's transplant status
(he got one!) but he did have to go back to surgery for an arterial bleed but
all is fine now and his ventilator has been removed! Keep praying for him and
tax deductible donations for his transplant fund can be sent to:
H.E.A.L.S of the South
PO Box 180813
Tallahassee, FL 32318
Please mark for Ron's transplant as these are kept separate.
His MELD was 35 so those of you who are also waiting for a transplant NEVER GIVE
UP HOPE and keep praying for that miracle for you too....... because miracles DO
happen! I pray that YOU are the NEXT miracle :-)

My Biospy Results

2007-03-30 09:13:52

Hi Everyone How ya'll doing??? Hope all is well with ya'll here!!
I was to tired yesterday to post this soo hmmm well my Dr.visit Wednesday on
the biospy results really didnt go well I still have quite a bit of bacteria in
my stomach so he put me back on 2 stronger antibiotics for 30 days and more
prevacid for the inflammed small intestine..I also asked him about a liver
biospy and when can I get it done,he said not until the bacteria is cleared up
and I asked him "why" in which now this makes sense and why he didnt tell me
this a month ago who knows..But he said if he was to stick a needle in my liver
with that bacteria that it could cause the bacteria to seep into my liver and
that I have enough going on without that too..It makes sense now,so anyways I am
on antibiotics for another 30 days I go back to see him June 20th to see how Im
feeling and if any changes and set up yet again another egd (3rd one) to see if
the bacteria is gone if it is he will set me up for a liver biospy then..
I also talked to him about a gastric bypass and he said "go for it" that when
the bacteria is gone then to talk to my family Dr.about it I said so it would be
ok to do it even with the Hep and he said well lets put it this way "do you want
to have complications with obesity or the problems you are facing now with your
Hepatitis without the obesity" so I said if I can I am going to do it,becuz I
keep gaining and losing like a yoyo and its hurting my knees more and my
self-esteem alot so yep im going for it and maybe then I can work somewhere
part-time (possibly) and feel like im somebody again
He also wants me to go to Dr.McCue get another series of Hep A&B shots,tetanus
shot,pnemonia shot and flu shot I asked him "why I already have the Hep A&B
shots but that I understand about the other shots needed" and he said its
because my immune system is shot he also told me to set up blood work with
Dr.McCue to check my liver enzymes to make sure they havent changed with all the
antibiotics I am dealing with right now and the stress changes in my life,so I
set this all up for this Monday..
OH And I got good news I get my first SSI check in June and they will get in
touch with me on back pay so this is good news for me for a change but I am not
going to just sit here and not do things for myself but to do my best to try and
get out there and do things and not let my illness or knees make me become a
hermit..I am hoping to get enough back pay to get me a small 1 or 2 bedroom
house somewhere,hehe
Anywho,I need to get off here and go to town to get some things so have a good
weekend everyone love Jan

Re: [HepCingles] Brain Fog (reposted by request)

2007-03-29 23:26:49

pity we can't send the attachments....... found old computer... but power
cord is broken so the other slides I have cannot get to thanks Pam.....
I've been pretty sick, not hep really, just lots of stuff..... hugs, sally

---------...and the beat goes on......." Sonny Bono.....I will say of the L-rd,
He is my refuge andmy fortress: my G-d; in Him will I trust.Psalm

Hepatic Encephalopathy/ w/URL

2007-03-29 20:50:35

sorry.... read second letter and I can get in there... sorry

---------...and the beat goes on......." Sonny Bono.....I will say of the L-rd,
He is my refuge andmy fortress: my G-d; in Him will I trust.Psalm

Re: [HepCingles] Some Good News For a Change

2007-03-29 16:17:13

YIPPPPPEEEEEEEE!!!!!!!!!!!!!!

Hepatic Encephalopathy/ w/URL and link to image

2007-03-29 10:48:50

hi dennis says page not found for me.... ????

Some Good News For a Change

2007-03-28 18:35:06

I was diagnosed last June. I live in the Baltimore, MD area and since then, I've
been waiting for a Scherring Plough test study to begin at Johns Hopkins. Well,
I started the study on April 5th. My viral load has gone from 8 million to 4
million to 9400!!! So, if anyone has the opportunity to participate in this
Scherring Plough study, I strongly recommend it. Further, the only side affect
I'm experiencing is a sore throat!
Go on line and find a similar study in your area.
Warm regards to all...
Donna
nsolitude <cascades91@...
Unfortunately the original full journal article with all of the
images and Tables is not available online except by purchase. The
copy published at Medscape only shows one image which is the Flow
Chart entitled 'Patient Care Guidelines'. The quality of the image
was poor so I copied it and enhanced it in photoshop, and then I
posted it to my photobucket album so you can see it (and copy it if
you want) by clicking on the following link if your're interested:
http://i23.photobucket.com/albums/b365/Phangeaux/Patient-Care-
Guidelines-Hep.jpg
Here is the medscape URL again:
http://www.medscape.com/viewarticle/406524

For Dennis

2007-03-28 18:26:46

Have a doc do an ammonia level on you Dennis. If elevated start on Lactulose
like most of the rest of us LOL I will be on it for the rest of my life but
it keeps the ammonia and confusion to a dull roar ;-) Sometimes I add
Neomycin when I feel like I am swinging upside down from a monkey bar and making
poor decisions. Some have good results with Rifaximin.
Nutrition and cirrhosis

INFO: Low-Antigen-Content Diet (LAC-diet)

2007-03-28 11:56:25

This is a copy of an INFO post I made to Daniel's list in the UK. The
introduction explains the purpose.

Re: Hepatic Encephalopathy/ w/URL and link to image

2007-03-28 04:29:15

Unfortunately the original full journal article with all of the
images and Tables is not available online except by purchase. The
copy published at Medscape only shows one image which is the Flow
Chart entitled 'Patient Care Guidelines'. The quality of the image
was poor so I copied it and enhanced it in photoshop, and then I
posted it to my photobucket album so you can see it (and copy it if
you want) by clicking on the following link if your're interested:
http://i23.photobucket.com/albums/b365/Phangeaux/Patient-Care-
Guidelines-Hep.jpg
Here is the medscape URL again:
http://www.medscape.com/viewarticle/406524

Hep C sufferer jailed for syringe attack

2007-03-27 23:25:06

Hep C sufferer jailed for syringe attack
Tuesday May 15 16:54 AEST
A hepatitis C sufferer who injected a sunbaking backpacker with a blood-filled
syringe has been jailed for five-and-a-half years.
Louis James Champion, 36, pleaded guilty in Brisbane District Court to one count
of sexual assault and one of wounding with intent to transmit a disease over the
attack at Hervey Bay in May last year.
The court heard the 26-year-old female backpacker had fallen asleep on the beach
at Pialba on May 28, and woke up to find Champion on top of her.
Prosecutor Jacob Robson told the court when the woman awoke Champion stabbed her
in the thumb with the blood-filled syringe.
He said Champion suffered from hepatitis C and the woman had to endure a six
month wait for blood tests to clear her of the disease.
The court heard Champion had been addicted to drugs and alcohol since his early
20s.
Judge Helen O'Sullivan sentenced Champion to five-and-a-half years jail and
listed him as a serious violent offender, meaning he must serve at least 80 per
cent of his sentence.
"Your actions were that of a sick man which most of the community would find
abhorrent," Judge O'Sullivan said.
http://news.ninemsn.com.au/article.aspx?id=267425

Acupuncture Gets Worldwide Exposure From Oprah Winfrey

2007-03-27 22:03:23

Acupuncture Gets Worldwide Exposure From Oprah Winfrey
Earlier this year, acupuncture and Oriental medicine got a huge boost in a
featured segment of the Oprah Winfrey Show, which reaches an estimated 48
million Americans each week and is shown in 126 other countries. On Feb. 13,
Oprah and an audience member received acupuncture treatments from Daniel Hsu, a
licensed acupuncturist from New York. The acupuncture segment was part of "Ask
Dr. Oz," a popular periodic feature of the show, during which Mehmet Oz, MD,
answers audience members' questions about specific health issues.
Despite initial trepidations about the needle insertion, Oprah commented that it
didn't hurt. In fact, once the needles were removed, she commented, "I felt it,
[but it's] not as bad as getting your blood drawn. It's not bad, not bad at
all." Her guest, Angela, who received a full treatment for shoulder pain, had
even better results, commenting that her chronic pain was gone, following
treatment with approximately a dozen acupuncture needles.
"I feel rejuvenated," Angela said. "The pain that I had was a constant,
radiating pain, and I don't feel it ... I don't feel it. I feel wonderful."
To view the Feb. 13, 2007 episode of the Oprah Winfrey Show online, visit:
http://www2.oprah.com/tows/pastshows/200702/tows_past_20070213.jhtml. To find
out more about acupuncture and Oriental medicine, visit
http://www.acupuncturetoday.com.

Drug axed over liver failure deaths

2007-03-27 10:09:00

Drug axed over liver failure deaths
Last Modified: 15 May 2007
Source: PA News
A prescribed drug was withdrawn from the Irish market after three people died
from liver failure.
Six other patients also needed liver transplants after taking nimesulide.
The Irish Medicines Board (IMB) ordered the suspension of the drug, which has
not been approved in a number of other countries including the UK.
Nimesulide is a non-steroidal anti-inflammatory medicine used for the treatment
of acute pain, the symptomatic treatment of painful osteoarthritis and period
pains. It is available only on prescription.
Common brand names for the drug includes Aulin, Mesulid and Mesine.
The recall only applies to oral tablets and granules. Gels are not affected.
Patients taking these medicines are being warned to contact their pharmacist for
advice.
IMB said it previously advised healthcare professionals that liver damage is a
rare but serious side effect of the drug.
Since nimesulide was first licensed in Ireland in 1995, a total of 53
liver-related adverse reaction reports have been received.
This includes nine cases of liver failure, six who needed life saving surgery at
the National Liver Transplant Unit at St Vincent's University Hospital, Dublin.
http://www.channel4.com/news/articles/society/health/drug+axed+over+liver+failur\
e+deaths/511627

Re: Hepatic Encephalopathy/ w/URL

2007-03-27 06:58:59

I see that the article is from MedScape (I assume that is where Pam
got it) and in order to view it you will have to register at
Medscape, which is a great site for keeping up on alot of the
research and current perspectinves on hep-c. The required
registration is probably why Pam didn't post the URL.
It may be possible to find it at another website, I'll continue to
look but here is the URL at Medscape:
http://www.medscape.com/viewarticle/406524

House Committee Passes Six Veterans' Health Care Measures

2007-03-26 21:43:53

House Committee Passes Six Veterans' Health Care Measures
The House Veterans' Affairs Committee on Tuesday by voice vote approved six
veterans' health care bills that would expand free care for war veterans,
establish brain injury research centers and make chiropractic care more
accessible, among other things, CQ Today reports. Under one bill (HR 612), free
health care for returning troops would be expanded from two to five years
(Yoest, CQ Today, 5/15). The bill, which is geared toward veterans from the
Persian Gulf War through present and future conflicts, aims to help those
veterans who have health problems that appear years after they have completed
military service (Leonatti, CongressDaily, 5/16). The committee by voice vote
approved a substitute amendment to the legislation that would expand health care
available retroactively to all veterans who meet the bill's criteria, rather
than only those veterans discharged after its enactment. No funding estimates
were included with the measure.
The committee also approved legislation (HR 2199) that would establish traumatic
brain injury research centers and mandate a comprehensive program for treating
traumatic brain injuries at Veterans Affairs health centers. Another bill (HR
1863) approved by the committee would authorize mobile veterans' centers to
provide advice on the disability claims process.
The committee on Tuesday approved legislation (HR 1470) that would expand the
availability of chiropractic care to 75 VA medical centers by 2009 and all VA
medical centers by 2011. In addition, the committee approved legislation (HR 67)
that would establish a grant program for state veterans' outreach programs. The
bill was approved with a substitute amendment by Rep. John Hall (D-N.Y.) that
would require county veterans' services offices to submit a three-year spending
plan to be eligible for the grants.
The committee also approved legislation (HR 2239) that would expand eligibility
for vocational rehabilitation to disabled troops not yet discharged from the
military but who are likely to be discharged because of their condition. The
committee on Tuesday also voted to refer back to subcommittee legislation (HR
2219) that would authorize $7.5 million to establish a 24-hour suicide
prevention hot line (CQ Today, 5/15).
VA Memo
VA on Friday sent veterans organizations a four-page memo in response to a
recent McClatchy investigation looking into VA's characterizations of the
success of its health system, McClatchy/Raleigh News & Observer reports. The VA
memo sent Friday said that McClatchy "makes a valid case that we need to be more
careful with our numbers and our public statements," adding that the VA had not
intended "to deliberately mislead anyone." The memo added that "VA has never
claimed that the [RAND] study showed that we performed better than any other
health care system in the nation." However, according to McClatchy/News &
Observer, "comments pulled from VA and congressional Web sites indicate
otherwise" (Adams, McClatchy/Raleigh News & Observer, 5/16).
http://www.kaisernetwork.org/daily_reports/rep_index.cfm?DR_ID=44951

Digest Number 1930

2007-03-26 19:45:10

Hi Sonny. I have a friend Ron who is lying on the table RIGHT THIS VERY SECOND
getting his new liver :-) His meld was an unprecedented THIRTY FIVE! I
have never known anyone with a MELD that high that was still alive........... so
it CAN happen and always believe in miracles and good luck with finding that
RIGHT liver for you! Depends on the area of the country you are in. 20-30
is about average for the south and 30-40 is out in California.
Waving at Dennis! Thanks for posting! :-) I am leaving for DC (and a quick
stop on Saturday the wrong direction to see my newly transplanted friend) on
Saturday. I will be gone a week. Take care of each other!
Peace
Pam

Heavy Multivitamin Use May Raise Prostate Cancer Risk

2007-03-26 13:35:05

http://www.forbes.com/forbeslife/health/feeds/hscout/2007/05/15/hscout
604616.html
Heavy Multivitamin Use May Raise Prostate Cancer Risk
05.15.07, 12:00 AM ET
TUESDAY, May 15 (HealthDay News) -- Popping more than one
multivitamin a day could boost a man's risk for prostate cancer by
nearly a third, according to a new study from the U.S. National
Cancer Institute.
"Taking them more than seven times a week was associated with a 32
percent increased risk of advanced prostate and for fatal prostate
cancer [it had] nearly a doubling of risk, compared to men who did
not take multivitamins," said researcher Dr. Michael F. Leitzmann, an
investigator in the NCI's division of cancer epidemiology and
genetics.
On the other hand, "Taking multivitamins seven times a week was not
associated with an increased incidence of prostate cancer," he added.
The association with heavy use of multivitamins and increased risk
was strongest for men with a prior family history of prostate cancer
or those who took individual micronutrient supplements such as
selenium, beta-carotene or zinc, said a report by Leitzmann and his
colleagues in the Journal of the National Cancer Institute.
"We enrolled nearly 300,000 men who filled out questionnaires about
their multivitamin use in the previous 12 months," Leitzmann
said. "We followed them for up to six years, checking on the
occurrence of total prostate cancer and also more serious forms of
prostate cancer."
It's unclear how excessive use of multivitamins could boost prostate
risk. According to Leitzmann, the study was epidemiological, "and
typically these studies are not able to rule out other factors
related to the use of multivitamins."
However, an accompanying editorial notes that many of the supplements
have strong antioxidant properties. The new study adds to "growing
evidence that questions the beneficial value of antioxidant vitamin
pills in generally well-nourished populations," according to the
European experts who wrote the editorial. The findings
also "underscore the possibility that antioxidant supplements could
have unintended consequences for our health," the experts wrote.
The NCI will not be giving men any new advice about the use of
multivitamins based on the study, Leitzmann said. "At this point, we
have no statement regarding any change in the way men use
multivitamins," he said.
The finding does confirm the results of an even larger study reported
two years ago by investigators at the American Cancer Society.
They followed almost a half-million men for 18 years and wrote
that, "the death rate from prostate cancer was marginally higher
among men who took multivitamins regularly (15 or more times a month)
compared to nonusers."
The increased risk in the study was smaller -- about 7 percent
overall, 12 percent in the first four years of follow-up. It was not
found in men who took additional supplements of vitamins such as A, C
and E.
That difference might be due to the way the ACS study counted the use
of the supplements, said Victoria Stevens, a society epidemiologist
and lead author of the report. In both studies, the increased risk
was seen essentially in men who took the most supplements, Steven
said.
"Overall, the observations are similar," Stevens said.
As for advice about multivitamins, she said the society has already
advised against them -- not just for prostate cancer, but in general.
"We have our standard guidelines that don't really recommend the use
of multivitamin supplements," Stevens said. "We feel that the best
way for people to get their vitamins is through natural food sources.
Pregnant women and others who might need them should use balanced,
basic multivitamin supplements that give no more than they get from
the daily diet."
More information
There's more on prostate cancer at the U.S. National Cancer Institute.
http://www.cancer.gov/cancertopics/types/prostate

Consumers Advised To Avoid Raw Oysters

2007-03-26 09:44:58

Consumers Advised To Avoid Raw Oysters
State and local health officials are advising consumers to avoid eating raw
oysters from Puerto Peņasco, Mexico.
Raw oysters are better known as Rocky Point, following the identification of 13
cases of hepatitis A associated with raw oyster consumption.
Eleven cases have been identified in Maricopa County, and one each in Pima and
Yuma counties. All reported traveling to Rocky Point between March 8 and March
25, and eating raw oysters at several different locations, including oyster
farms and street vendors. Mexican health officials are investigating to identify
possible sources of the contaminated oysters.
"These cases are a reminder there is a real risk of getting sick from uncooked
shellfish - regardless of where it is from," said State Epidemiologist Ken
Komatsu. Illnesses associated with eating uncooked oysters are not uncommon and
have been reported in numerous states, including California, Florida, Texas,
Alabama, and Louisiana.
Illness resulting from hepatitis A infection may include fever, fatigue, loss of
appetite, nausea or abdominal discomfort, which may be followed within a few
days by jaundice. Hepatitis A can take from 15 to 50 days to develop, however it
usually takes about 30 days. The illness is rarely fatal, and is usually of mild
to moderate severity.
Due to a higher risk of complications, anyone with any other form of hepatitis
or underlying liver disease and who ate raw oysters in Puerto Peņasco during
this time may wish to consult with their health care provider. There is an
effective vaccine that virtually eliminates the possibility of getting hepatitis
A. The Centers for Disease Control advises people traveling to countries where
hepatitis A is common should consider getting immunized against hepatitis A.
Hepatitis A can be contracted anywhere. It is usually spread from person to
person by putting something in the mouth that has been contaminated with the
stool of a person with hepatitis A. To avoid contracting hepatitis A, always
wash your hands after using the bathroom, changing a diaper, or before preparing
or eating food.
http://www.emaxhealth.com/75/12058.html

Spanish Hep C anaesthetist jailed

2007-03-26 01:06:14

Spanish Hep C anaesthetist jailed
A Spanish anaesthetist with hepatitis C has been sentenced to nearly 2,000 years
in prison for infecting hundreds of patients with the virus.
Juan Maeso, 65, infected 275 people between 1988 and 1997, by injecting himself
with a morphine syringe before using the rest on a patient.
Valencia's Provincial Court sentenced Mr Maeso, who is a morphine addict, to
1,933 years in jail.
However the most he can serve under Spanish law is 20 years.
He was also ordered to pay 500,000 euros ($680,000) in damages to each of the
victims or their survivors.
Mr Maeso is said to have infected patients when he worked in four hospitals in
the Valencia area.
Four of those he infected with the virus have since died.
http://news.bbc.co.uk/2/hi/europe/6657509.stm

Prolonged Therapy with Pegylated Interferon/Ribavirin May Improve Odds of Sustained HCV Clearance

2007-03-25 16:29:24

Prolonged Therapy with Pegylated Interferon/Ribavirin May Improve Odds of
Sustained HCV Clearance
Recent studies have provided increasing evidence that among chronic hepatitis C
patients treated with pegylated interferon plus ribavirin, rapid virological
response (RVR) at week 4 is a good predictor of sustained virological response
(SVR) 24 weeks after completion of therapy. Further, mathematic models suggest
that in patients with genotype 1 HCV, the SVR rate directly correlates with the
duration of treatment after HCV RNA becomes undetectable.
As reported at the 42nd Annual Meeting of the European Association for the Study
of the Liver last month in Barcelona, Italian researchers conducted a study to
evaluate SVR in relationship to RVR among 663 genotype 1 patients who received
pegylated interferon plus ribavirin for either the standard 48-week course (n =
221) or individualized treatment durations of 24, 48, or 72 weeks (n = 442). In
the individualized treatment group, those without RVR were treated for 48 or 72
weeks based on whether HCV RNA was undetectable at week 8 or week 12.
Results
a.. 236 patients (54%) in the individualized duration arm and 121 patients
(55%) in the standard duration group had undetectable HCV RNA at week 8.
b.. At week 12, HCV RNA became undetectable for the first time in 50 patients
in the individualized duration arm and 15 in the standard duration group.
c.. Proportions of non-responders at week 12 in the 2 arms were 155 (34%) and
85 (38%), respectively.
Among patients who were HCV RNA negative at week 8, 111 of 318 (35%) in the
individualized duration arm and 45 of 163 (28%) in the standard duration group
achieved SVR (P = 0.12).
d.. When patients who became negative for the first time at week 12 were
analyzed separately, the corresponding SVR rates were 32 of 50 (64%) and 5 of 15
(33%) (P = 0.07).
e.. In the latter subgroup, the only factor significantly associated with SVR
was longer treatment duration (P = 0.0001; OR 1.68).
f.. Relapse rates did not differ significantly in the 2 treatment arms (5% vs
4%).
g.. Dropout rates were 15.3% in the individualized duration arm and 13.1% in
the standard duration arm.
Conclusion
The investigators concluded that, "Results of this randomized controlled trial
confirm that prolonging treatment [beyond] 48 weeks allows better SVR even in
the subgroup of patients who clear HCV RNA at week 12 from the start of
treatment."
IRCCS Italy; Ospedale Canosa, Canosa, Italy; Ospedale Casarano, Canosa, Italy;
Ospedale Venosa, Venosa, Italy; Universita di Palermo, Palermo, Italy;
Policlinico Umberto i Dell'Universita, Rome, Italy; Hospital Sandro Pertini,
Rome, Italy; Ospedali Riuniti Foggia, Foggia, Italy; Ospedale Brindisi,
Brindisi, Italy.
05/11/07
Reference
A Mangia, N Minerva, D Bacca, and others. In pts who clear HCV RNA at week 12,
SVR is higher after 72 than after 48 weeks tx: results of a randomized
controlled trial (RCT). 42nd Annual Meeting of the European Association for the
Study of the Liver. Barcelona, Spain. April 11-15, 2007.
http://www.hivandhepatitis.com/2007icr/easl/docs/051107_a.html

Interesting

2007-03-25 11:25:50

The first successful cornea transplant was done by Eduard Zirm in the year 1905.
In the same way, kidney transplant was done in the year 1954 by Joseph Murray
and liver transplant was by Thomas Starzl in the year 1967. These transplants
were successful and also lead this innovative technique to greater heights.
Organ transplants are more commonly taking place in the developed countries
rather than in the developing countries. This is because these countries have
forged various laws to make these more available to the people. Kidney
transplants as well as the liver transplants are the ones taking place more
commonly these days.
http://www.online-family-doctor.com/blog/2007/05/11/organ-transplant/

'Why my race has meant donor delays'

2007-03-25 08:07:35

'Why my race has meant donor delays'
By Jane Elliott
Health reporter, BBC News
Tony Rouf has already waited 10 years for his third kidney
transplant.
But he is quite aware that he could spend many more years on the
waiting list - and that the reason for the lengthy delay is because he is from
an ethnic minority.
Tony was just eight when he had to have a kidney removed after he
developed a tumour.
He suffered from high blood pressure for the next 10 years, and at
18 started dialysis after the condition of his remaining kidney deteriorated.
Losing hope
Tony, from London, who is of Euro/Asian ethnicity, had his first
transplant at the age of 19, but this only lasted a year.
He had to go back on the waiting list, and after about a year had
his second transplant, but the kidney had to be removed the next day as it was
found to be damaged.
"At first when you go on the waiting list you hope every telephone
call might be the one. But then you see others getting their transplants and you
start to lose hope," he said.
"Now I am pretty much resigned to the fact that I will have to stay
on dialysis for some time to come."
Tony said that when he first went on the register he was not aware
that his ethnicity might delay his chances of getting a kidney.
"But now I know," he added.
"I always carried a donor card and still do, there are other organs
I can still donate.
"I would just say to those who do not carry a card to imagine that
it is one of their family who need it."
Small percentages
Statistics show that black and Asian people, like Tony, are over
three times more likely to need a kidney transplant than the general population
because they have a higher incidence of diabetes and high blood pressure,
leading to kidney failure.
And their chance of a successful transplant is greater if they get
an organ from someone from the same ethnic group.
But Asian and black donors make up fewer than 2% of the non-live
donors, and recipients have to wait twice as long for suitable organs.
An Asian person waits an average of 1,496 days for a kidney
transplant, compared with 1,389 days for a black recipient and 772 days for
someone who is white.
Although the numbers of donors are increasing among the black and
other ethnic minority communities, even more are needed.
In addition, nearly one in 10 of all cornea transplants carried out
in the UK helps an Asian person regain their sight.
Asian people are more likely to need a cornea transplant because of
keratoconus, a debilitating disease which usually affects both eyes, causing
worsening vision distortion.
Furthermore, more than 6% of people on the liver transplant list are
Asian.
This is because of viral hepatitis - types B and C - which can lead
to liver damage, and liver failure is more prevalent in the Asian population.
'Give something back'
Gurch Randhawa, an expert in transplantation and professor of public
health in diversity at the University of Bedfordshire, said: "There are hundreds
of Asian and black people on the transplant list who are literally counting on a
donor to save their lives.
"The shortage of ethnic minority donors is a serious issue but it's
a problem we can all do something about by discussing donation and joining the
register.
"We are taking this campaign into the grassroots community and
trying to start a conversation. We are saying to them that there is someone in
your community suffering and dying and this is how you can give them something
back."
UK Transplant campaigns and marketing manager Tamsin May added:
"There is a shortage of organ donors of all ethnic backgrounds, but the problem
is particularly acute among the black and south Asian communities.
"Transplants tend to be more successful when donor and recipient
share the same ethnic background and the shortage of suitable donors means black
and Asian people spend much longer waiting for a transplant.
"We need people to talk about their wishes for organ donation and
join the register."
http://news.bbc.co.uk/1/hi/health/6529463.stm

Does Cognitive Function Worsen during Retreatment of Chronic Hepatitis C with Pegylated Interferon plus Ribavirin?

2007-03-24 22:47:09

Does Cognitive Function Worsen during Retreatment of Chronic Hepatitis C with
Pegylated Interferon plus Ribavirin?
Treatment of chronic hepatitis C with pegylated interferon plus ribavirin can
cause or exacerbate depression. The effect of treatment on cognitive function
are largely unknown, although there are numerous anecdotal reports by patients
of cognitive impairment during and after therapy with pegylated interferon and
ribavirin.
The aim of the current study, published in the May 2007 issue of Hepatology, was
to determine whether retreatment with pegylated interferon plus ribavirin
adversely impacts cognitive function in patients with chronic hepatitis C.
Prior non-responders to interferon were retreated with pegylated interferon
alfa-2a (Pegasys) plus ribavirin for 24 (n = 177) or 48 weeks (n = 57) in the
Hepatitis C Antiviral Long-term Treatment against Cirrhosis trial (HALT-C).
Cognitive function was prospectively assessed using a battery of 10 standardized
neuropsychological tests at weeks 0, 24, 48, and 72. Cognitive impairment was
defined based upon a global deficit score. The Beck Depression Inventory and
Brief Symptom Inventory were used to assess mood.
Results
a.. The 57 subjects who completed 48 weeks of antiviral therapy reported
significant increases in difficulty concentrating, emotional distress, and
symptoms of depression, all of which improved after cessation of therapy (P <
0.0001).
a.. However, the frequency of cognitive impairment did not increase during the
first 24 weeks of treatment in 177 patients (34% versus 32%, P = 0.64), nor in
the 57 patients who completed 48 weeks of treatment (P = 0.48).
Based on their findings, the study authors concluded, "Retreatment of prior
non-responders with peginterferon and ribavirin was not associated with
objective evidence of cognitive impairment as measured by a comprehensive
battery of neuropsychological tests."
"The lack of cognitive impairment is reassuring and suggests that self-reported
symptoms of cognitive dysfunction are more likely related to the systemic and
psychiatric side effects of antiviral treatment rather than measurable changes
in cognition," they continued.
It seems unlikely that this study will resolve the question of the possible
adverse effects on cognitive function of patients receiving the pegylated
interferon plus ribavirin; clearly, more research is needed in this area.
05/11/07
Reference
R J Fontana, L A Bieliauskas, K L Lindsay, and others (the HALT-C Trial Group).
Cognitive function does not worsen during pegylated interferon and ribavirin
retreatment of chronic hepatitis C. Hepatology 45(5): 1154-1163. May 2007.
http://www.hivandhepatitis.com/hep_c/news/2007/051107_a.html

One Grad Ready to Give Back

2007-03-24 13:26:21

One Grad Ready to Give Back
Christine Webb - This weekend seniors at Nazareth College will graduate with
high hopes for the future. For one senior, it's her time to give back -- for
something extraordinary that happened in her life.
When Marissa Emple was 101 days old, back in 1985, she was the youngest person
ever to receive a liver transplant.
Her picture appeared all over the papers--even in Life magazine.
Marissa said, "There was about a 10-20 percent chance I would survive the
surgery....and even less if I developed an infection post surgery."
Marissa was born with a rare disorder --her liver didn't function properly.
"By the time they realized what it was, I had 2 weeks to live," she said. "So it
was a rough prognosis."
Now 22 years later, Marissa is a music therapy major at Nazareth preparing to
graduate.
"It's extremely important for me to make a difference," she said.
Marissa has had no complications from the liver transplant. In fact, during a
recent concert she even met the doctor who saved her life.
She knows she is lucky. "It was a really big risk.and I'm so glad they advocated
for me."
After graduation Marissa plans to take part in a music therapy internship at the
Golisano Children's Hospital at Strong.
http://www.13wham.com/guides/health/story.aspx?content_id=e72cb802-ddde-4f9b-883\
8-7081d0a23aa6

Re: [HepCingles] Chef Michael Ivy awaits liver transplant to save his life

2007-03-24 07:16:55

hi pam, whats his melt score?mine is 20 and was told i'd have a transplant in 6
months to a year! i hope it took me 10 years to get on the list! the higher yor
score the closer you get to the transplant! sometimes you have to take a hep c
liver, the liver may heal it's self of hep c even if was hep c'd! good luck to
him!!
good bless
sonny
PeachStatePam <figment@...
Chef Michael Ivy awaits liver transplant to save his life
Restaurateur who once ran Michael's Midtown Cafe waits for life-saving liver
transplant
Sunday, May 06, 2007
By RHODA A. PICKETT
Staff Reporter
It may seen a cruel irony that Michael Ivy, not long ago one of Mobile's most
popular chefs, doesn't have much of an appetite for anything.
A diagnosis of hepatitis C in 2000 has so deteriorated Ivy's liver that he now
needs a transplant. The restaurateur who once watched over the preparation and
serving of fine cuisine at Michael's Midtown Cafe on Florida Street can now eat
only fresh vegetables.
"It's quite the challenge now. I just can't eat anything anymore. It's not fun."
Soon he will have to move from the recreational vehicle park he has called home
for the last three months.
"I'm going to have to go live with family," he said, adding that his doctors
will soon perform a procedure that will make it difficult of him to care for
himself. "I can't live independently anymore."
He said that he has end stage liver disease. "What it means is you're going to
die if you don't get a liver."
Ivy said that he had been on the national liver transplant list after he was
diagnosed, but his name was taken from the list when his body responded well to
some medication he was given. Then, more than 18 months ago, his condition
worsened and his name was put back on the transplant list, he said.
Liver disease has been something that Ivy said he has hesitated sharing with
friends. He said he has personal reasons for talking to the Press-Register about
his condition and his need for a liver transplant. The other reason is to
encourage people to become organ donors and to tell their relatives of those
wishes.
According to the American Liver Foundation Web site, there were 6,500 liver
transplants performed in the U.S. in 2005. The national liver transplant waiting
list is prioritized so the sickest people always go to the top of the list.
About 17,000 Americans are currently on a waiting list for a liver transplant,
according to the Web site.
On this particular day, Ivy preferred sitting outdoors at the makeshift patio
area formed from a rectangular cream-colored carpet remnant with a large wooden
cable spool serving as a table. Although the red short-sleeved T-shirt and gray
sweat pants appear slightly oversized, it's the blackish blue bruises up and
down his forearms that indicate Ivy's poor health.
"They look good today," he said.
This particular Tuesday afternoon was what Ivy described as "moderate day." He
said he doesn't get out much because trips to the pharmacists or the grocery
store are exhausting. Even sharing a breakfast with family members at a local
restaurant requires energy he no longer has.
Ivy said he tried to keep his condition private, selling his restaurant and then
settling for jobs that wouldn't require the amount of time and energy running
the restaurant did. He started working as the chef at 15 Place, the day center
for the homeless in downtown Mobile. He had also developed a program called Kids
Cafe in three public schools near downtown Mobile and he wrote a column for the
Press-Register's food section.
His worsening health caused him to eventually stop working altogether. He said
he went from making around $40,000 a year to about $13,000 annually that he
receives in disability income.
To make ends meet, Ivy first used funds in his individual retirement account.
When that was gone, he sold his house and used some of the profit from that sale
to purchase a recreational vehicle. He parked it a camp on Old Military Road.
"I couldn't pay the mortgage anymore," Ivy said. "I made just enough profit to
buy this. I just had to downsize, you know."
He does his own cooking in the RV, and when he gets tired from the effort, he
lies down on the couch for a few minutes and then gets up and continues.
He will soon move again.
"Since Thanksgiving it's been a really rapid decline," Ivy said.
Ivy said that since telling more people about his illness, he has received some
positive feedback.
"I have really been surprised at the people who have come forward," he said. "I
got several donations. It's kept me going the last couple of months."
The money has helped him pay expenses when he travels to New Orleans for his
doctor's appointments at the Tulane Transplant Center.
Friends and family are planning a benefit for Ivy on June 15 at the Blue Gill
restaurant on the Causeway.
Organizers hope to sell 300 tickets. There will be items available for a silent
auction and a handful of local chefs who once worked under Ivy will prepare some
five or six different entrees.
All the proceeds will go to the "Michael Ivy Special Fund Account" set up a
Regions Bank, said Henry Brewster, a Mobile attorney who oversees the account.
Donations can be made at Regions Bank branch.
"It's been really tough," Brewster said. "He really needs to get a transplant."
Brewster said that he and Ivy's brothers have taken Ivy to New Orleans on three
separate occasions to wait on a transplant. When a liver is found, two
candidates on the transplant list are called and have to be present. One
candidate has to remain on standby at the hospital until doctors determine
whether the liver is compatible with the transplant candidate undergoing
surgery, Brewster said. If it isn't compatible, the liver is reharvested and
given to the standby candidate.
"He's been up and down," Brewster said. "It's just yucky."
Ivy said he remains optimistic and the experience has taught him a few things.
"One of the really good things that has come out of this is I thought that
people liked me because of my food. I've been surprised at the amount of people
who have liked me in spite of my cooking. They have said, 'I want to help. I
love you.'
"I never really thought that they liked me for me. I really thought that they
tolerated me because I was a good cook. I thought it was because I danced well
and danced fast and as long as I danced, they would love me and compliment me. I
didn't realize that people didn't love me just because I cook, they loved me
just because they loved me.
"I certainly have a bag full of faults. And people know how surly I could be.
They have said so, publicly, in the newspaper."
After the fund-raiser, Ivy said he should have enough money to pay expenses for
six months.
Despite his illness, Ivy said he "has no bitterness in his heart" for the course
his life has taken.
"You are not measured by the things that you have, but by what you do when your
life is difficult. That's when the true grit comes out."
http://www.al.com/news/mobileregister/index.ssf?/base/news/117844334565390.xml&c\
oll=3

'Hepatitis goals need effort'

2007-03-24 07:10:43

'Hepatitis goals need effort'
Saturday, May 12, 2007
PACIFIC Island countries have been urged to take strong measures to implement a
regional plan to achieve the goals of controlling Hepatitis B.
The World Health Organisation's Expanded Program on Immunisation's regional
advisor for the Western Pacific, Dr Yang Baoping said a greater effort was
needed to reach the regional goals.
He was speaking at the third Pacific Immunisation Program Strengthening workshop
in Nadi yesterday.
Dr Baoping said the short-term regional goal was to have less than two per cent
chronic HB infection rates among children up to five years of age while the
final goal was to have less than one per cent chronic infection rates.
He said strategies that would help achieve these goals included strengthening
immunisation services and using advocacy and social mobilisation to increase
awareness among parents and health workers.
He said the prevention of HB transmission from mother to child during childbirth
was also important because infected infants were likely to suffer chronic
infection leading to their premature death as young adults.
Meanwhile, University of Melbourne associate professor, Doctor Tilman Ruff said
without immunisation, 2.2 per cent of babies born annually in the Western
Pacific region would be expected to die of HB-related causes later in their
life.
"HB currently causes more deaths than any other disease targeted by universal
immunisation," he said.
Dr Ruff said HB was different from other vaccine-preventable diseases because
most infections did not have symptoms and therefore would go unrecognised until
a complication developed usually over decades. "Unlike most vaccines given at
birth, preventing HB infection prevents premature adult death rather than child
death. It is also the first vaccine against cancer and the only infant vaccine
where the timing of first dose within 24 hours of birth is critical," he said.
Dr Ruff said without a high coverage of the HB birth dose, infection rates could
not be lowered.
http://www.fijitimes.com/story.aspx?id=62472

Causes of Death in Individuals with Hepatitis B or C

2007-03-23 22:14:40

Causes of Death in Individuals with Hepatitis B or C
Hepatitis B and C can lead to severe liver damage, including cirrhosis and
hepatocellular carcinoma, and are common causes of death related to liver
disease.
As reported in the April 2007 issue of Hepatology, researchers conducted a large
study to investigate all-cause mortality among individuals with HBV and/or HCV
in a community-based setting. The study population included individuals with
viral hepatitis reported to the New South Wales state health department in
Australia between 1990 and 2002:
a.. 39,109 with HBV;
b.. 75,834 with HCV;
c.. 2,604 with HBV-HCV coinfection.
Data were probabilistically linked to the National Death Index, and standardized
mortality ratios for all causes of death were calculated and adjusted for age,
sex, and calendar year.
Results
a.. The number of deaths identified by the linkage were:
a.. 1233 (3.2%) in patients with hepatitis B;
b.. 4008 (5.3%) in patients with hepatitis C;
c.. 186 (7.1%) in HBV-HCV coinfected patients.
b.. Standardized mortality ratios revealed an increased risk of liver-related
death:
a.. 12.2 for patients with HBV;
b.. 16.8 for patients with HCV;
c.. 32.9 for HBV-HCV coinfected patients.
c.. Mortality ratios also showed an increased risk of drug-induced death:
a.. 1.4 for patients with HBV;
b.. 19.3 for patients with HCV;
c.. 24.7 for HBV-HCV coinfected patients.
d.. In people with hepatitis C, the increase in the risk of death from
drug-related causes was significantly greater than from liver-related causes (P
= 0.012).
e.. The greatest excess risk was observed in women age 15-24 years.
Conclusion
"All groups [with HBV and/or HCV] had increased risk of liver-related death
compared with the standard population, with the greatest excess in people
diagnosed with hepatitis B and hepatitis C coinfection," the researchers
concluded. "Our data highlight that young people with hepatitis C and with
[HBV-HCV] coinfection face a higher mortality risk from continued drug use than
from their infection, whereas the main cause of hepatitis B death was liver
related."
05/15/07
Reference
F Tacke and C Trautwein. Causes of death in hepatitis B and/or C virus
infected-people-lessons for clinical practice. Hepatology 45(4): 1076-1077.
April 2007.
http://www.hivandhepatitis.com/hep_c/news/2007/051507_c.html

Pineapple: A Sweet, Nutritious Treat

2007-03-23 20:59:21

Pineapple: A Sweet, Nutritious Treat
A healthy staple for centuries, the pineapple is a tropical fruit that packs in
the vitamin C and body-building mineral manganese.
By Nick Kolakowski
WebMD the Magazine -- Feature
Reviewed by Kathleen M. Zelman, LD, RD, MPH
Prickly on the outside, sweet and juicy within, the pineapple has been a healthy
staple for centuries. Native to Brazil and Paraguay, the fruit arrived in
Central America and the West Indies via migrating tribes centuries before
Columbus. European explorers in the 16th century then carried the sweet-tart
treat as far as India, the Philippines, and China. It's since become a major
commercial crop everywhere from Hawaii to South Africa, and no wonder:
One cup of pineapple has only 74 calories and provides 94% of your RDA of
vitamin C. It's also high in manganese, an important mineral for the body's
muscle tone and nerve and bone health. A good source of dietary fiber, pineapple
contains the enzyme bromelin, which breaks down protein and may aid in digestion
and even help the body heal.
For other natural sources of manganese, reach for raspberries, soybeans, and
spinach.
http://www.webmd.com/food-recipes/features/pineapple-a-sweet-nutritious-treat?ec\
d=wnl_din_051407

Hepatitis C Choices in Care Workshop

2007-03-23 08:29:05

Hepatitis C Caring Ambassadors Program presents
Hepatitis C Choices in Care Workshop
August 11-12, 2007
Denver, Colorado
Go to hepcchallenge.org and click on Choices in Care, Denver.
What participants said about the 2006 Choices in Care workshop;
- Overall Excellent! Many Thanks
- Great conference! Very beneficial and informative! Good Qi!
- Great, well-rounded presentations. Good teamwork mirrors the desired
integration of care. Thank you!!
- I thank you for caring.
- I couldn't praise the conference highly enough. I appreciated the
lack of hucksterism and marketing. Bravo for the mix of allopathic and
complementary approaches. If only you could scale up and reach the nation with
these presentations.who knows? Please keep up the good work. Thank you!!! May
all beings be well.
Advance registration is required. Tuition $25 with lunch included each day.
Please pass this on to any and all who may be interested. Thank you.
Lorren Sandt
Caring Ambassadors Program, Inc.
Hepatitis C Program Director
503-632-9032
lorren@...
Hepatitis C: Choices now on our website at: hepcchallenge.org
HepCChallenge.org ~ LungCancerCAP.org ~ LungCancerGuidebook.org ~
CaringAmbassadors.org
"We believe strongly in the power of people working together, and that, by doing
so, we will make far more significant advances than could be made by any group
or discipline working on its own."
Choice, health, and wellness for people with chronic disease.

IAC Express #663

2007-03-23 05:35:55

IAC Express #663
IAC Express
Immunization news from the Immunization Action Coalition
A web page version of this issue is available at
http://www.immunize.org/express/issue663.asp
===============================================================
Issue Number 663
May 14, 2007
CONTENTS OF THIS ISSUE
1. CDC updates readers on supply of vaccines containing
varicella-zoster virus
2. MMWR highlights Hepatitis Awareness Month
3. CDC reports on epidemiology of chronic HBV infection in San
Francisco
4. CDC reports on hepatitis B prevention through universal
infant immunization in China
5. CDC publishes surveillance summary on health behaviors,
including influenza and pneumococcal vaccination
6. HAN issues official Health Advisory about influenza-
associated pediatric mortality and the increase of
Staphylococcus aureus co-infection
7. CDC announces addition of hepatitis A module to its "You Call
the Shots" training course
8. NASTAD releases primer on viral hepatitis policymaking and
programs
9. Former CDC director writes about changes in public health
from 1990-1993
10. CDC publishes record of February ACIP meeting
11. FDA clears first respirators for use in public health
medical emergencies
12. New pandemic influenza resources available
13. CDC updates its avian influenza web section
14. California Distance Learning Health Network to offer
pandemic influenza school preparedness training on May 17

Nautilus OK'd to test hep C drug

2007-03-23 02:35:10

Nautilus OK'd to test hep C drug
PARIS, May. 14 (UPI) -- Nautilus said Monday the U.S. Food and Drug
Administration cleared its potential hepatitis C treatment, oral Belerofon, for
a phase 1 trial.
Belerofon is a formulation of interferon-alpha that is intended to last longer
in serum and reach blood levels comparable to those obtained by injected
products.
"The development of an orally administered Interferon-alpha highlights the
potential of Nautilus Biotech's technology platform," said Paul Martin, the
firm's vice president of strategy. "It represents the promise of a third
generation of therapeutic protein drugs that can be taken more easily and have
great commercial potential to replace established injectable products."
The phase 1 trial of Belerofon is scheduled to begin later this year. Nautilus
said it will be an open-label, ascending dose study of four doses of the
investigational compound.
http://www.upi.com/Health_Business/Briefing/2007/05/14/nautilus_okd_to_test_hep_\
c_drug/3106/print_view/

Looming dread of HIV-Hep C co-infection in State

2007-03-22 14:57:44

Looming dread of HIV-Hep C co-infection in State
Source: The Sangai Express
Imphal, May 13: With lack of treatment facilities on one hand and no scientific
study being conducted on the issue, HIV-Hepatitis co-infection is becoming a
serious health issue posing threat to HIV positive people living in Manipur.
Talking to The Sangai Express on the sidelines of the convention for People
living with HIV/AIDS at State Guest House here today, a participating HIV
positive patient who has been co-infected with Hepatitis C pointed out that
HIV-Hepatitis Co-infection is becom- ing a serious health related issue many HIV
infected/affected people in Manipur today. He pointed out that there has been no
policy to conduct study and find out the extent of the HIV-Hepatitis
co-infection in Manipur.
However, as per his knowledge, out of every 10 HIV infected/affected persons, 8
of them are also infected with Hepatitis C in Manipur. During 2000-2001, ICMR
conducted a study in Churachandpur and Imphal, and come out with the findings
that the rate of HIV-Hepatitis co-infection is 98 percent in Churachandpur and
92 percent in Imphal, the patient informed, adding that treatment for Hepatitis
C on people who have already been infected/affected with HIV is very difficulty.
According to the recommendation of the World Health Organisation, a patient with
HIV-Hepatitis co-infection has to be given medicine course for one complete
year.
However, for getting such treatment in private, a patient has to shell out at
least Rs 5 to 7 lakhs in a year, which is not affordable to many, he lamented.
The patient further informed that of all the types of Hepatitis C from 1 to
five, the type III is common among the HIV-Hepatitis co-infection cases in
Manipur.
This type is easier to treat, he added. However, one dilemma being faced by the
patients, he said is that the HIV positive people whose CD4 cell count is below
200 are given ART drugs, and Hepatitis C affects the liver and so are the ART
drugs.
Therefore, how the treatment for Hepatitis C is to be carried out for patients
who are already under ART therapy is rather perplexing.
'We like to live for long in the society.
But we cannot decide whether we should get the ART treatment for strengthening
our immune system or save our lungs from deterioration', he said. It is a really
unfortunate that there has been no facility for treatment or intervention
programme or prevention programme for HIV-Hepatitis co-infection in Manipur so
far, said the patient, who has been trying to get the treatment since 2002 but
not able do so due to poor financial condition of his family, while drawing the
attention of the authorities concerned for taking up necessary measures in this
regard.
http://www.e-pao.net/GP.asp?src=10..140507.may07

Free seminar to offer hepatitis C information

2007-03-22 09:36:25

Free seminar to offer hepatitis C information
By Staff Reports
Argus Leader
Published: May 14, 2007
Learn more about hepatitis C at an educational seminar today at the Sioux Falls
VA Medical Center.
The seminar, titled "Living with Hepatitis C," will begin at 7 p.m. in the front
foyer of the VA center. The seminar is in observance of Hepatitis C Awareness
Month.
Information will be available on how hepatitis C affects the liver, how it
spreads and how it's treated. Hepatitis C is a virus spread through blood.
There is no charge for the event. For more information, call 336-3230, ext.
6158.
http://www.argusleader.com/apps/pbcs.dll/article?AID=/20070514/NEWS/705140309/10\
01

Activap disposes of risks in feminine hygiene disposal

2007-03-22 02:52:53

Activap disposes of risks in feminine hygiene disposal
A powerful germicide that is effective against potentially harmful bacteria and
viruses including HIV, Hepatitis B and C is part of a new integrated solution to
the safe disposal of used feminine hygiene products being offered by the UK's
leading hygiene services company Cannon Hygiene. Known as Activap, the
vapour-releasing germicidal system is designed to effectively start treating
feminine hygiene waste immediately at the point of disposal. Activap has been
proven in unique tests to destroy the bacteria in the waste, reducing the levels
by 99.999%. This has two simultaneous effects - Firstly, it effectively renders
safe a wide range of potentially infectious and harmful materials. Secondly, the
anti-bacterial system eliminates the odour causing bacteria, resulting in long
lasting odour prevention, unlike other scent based products which simply try to
mask the bad odours. In a study commissioned by Cannon Hygiene, microbiologist
Dr David Coates focused on the potential hazards which could affect washroom
users when no specialist feminine hygiene unit and germicide is provided and the
only facility is a conventional waste bin. The study revealed that untreated
sanitary waste can transmit harmful bacteria to users in infectious doses such
as Staphylococcus aureus, E.coli and Candida albicans, whilst there is also a
potential threat from viruses such as Hepatitis A, B and C. The combined Cannon
feminine hygiene system with Activap has been independently tested and proven to
be efficacious and is totally safe and non-toxic. Another major advantage is
that Activap contains highly effective yet entirely natural ingredients which
pose no threat to the environment. When used as part of Cannon's closed-loop
collection system, Activap has the potential to significantly reduce an
estimated two billion items of untreated sanitary waste being flushed down
toilets and into Britain's sewage systems every year. The new approach has been
introduced by Cannon Hygiene after working with development partner Biotal
Technologies, a company which develops innovative microbial and anti microbial
based alternatives to environmentally aggressive chemicals. Activap is available
as an integral part of Cannon's latest range of medical, clinical and feminine
hygiene disposal units. The system is enclosed within a range of
ergonomically-designed waste units incorporating an inner liner, modesty flap
and foot pedal. Cannon's professionally-trained staff collect, clean and
replenish the Activap units off-site according to customer needs. However,
Activap remains effective even in the event that a bin should remain full.
Cannon Hygiene's managing director Oliver Weisflog said, 'Our company pioneered
safe feminine hygiene disposal systems in the UK and has more than fifty years
experience in the field. This is the latest development in a long line of
innovations aimed at protecting people from risk. In this case it also offers
strong environmental credentials.'
http://www.practicalfm.co.uk/shownews.asp?id=10001

Drugs Users Are Increasingly More Cautious With Needles

2007-03-22 02:46:22

Drugs Users Are Increasingly More Cautious With Needles
Science Daily - Even though HIV can be well treated these days, drug users are
still more cautious about using needles than they used to be. That is the
conclusion of Colette Smit following her study into 25 years of HIV in the
Netherlands.
Earlier research had shown that since the introduction of the effective HAART
therapy, in 1996, homosexual men have more unsafe sex. Smit established that
drug users did not exhibit more risky behaviour once the perspective of
HIV-infected drug users improved. Due to improved hygiene drug users acquired
less HIV and less hepatitis C.
Hepatitis
Smit also examined coinfections. Due to the increased life expectancy relatively
more HIV patients have died from other causes in recent years. Infections as a
consequence of a reduced immunity (AIDS) remained the number one cause, but the
study also revealed an increase in hepatitis and liver-related death. The cause
of this was mostly hepatitis C.
Drugs users with both HIV and hepatitis C have a seven times higher chance of
dying from liver-related diseases than drug users with just hepatitis C. The
side effects of the therapy might also be the cause of the increased chance of
liver-related mortality. Patients need to be followed up for longer for definite
statements to be made about this.
Smit used data from various studies for her research, some of which were funded
by NWO. These studies had mainly been performed in Amsterdam over the past 25
years.
HAART
HAART is the acronym for Highly Active Antiretroviral therapy. This is a
combination of various antiviral drugs that suppress the HIV virus. The
introduction of HAART in 1996 led to a considerable fall in AIDS mortality.
The HAART therapy is not able to cure HIV. However there is a considerable
increase in the life expectancy of HIV-infected persons. Nevertheless this
remains considerably lower than that of the general population.
Note: This story has been adapted from a news release issued by Netherlands
Organization for Scientific Research
http://www.sciencedaily.com/releases/2007/05/070514102927.htm

Insurers Increasingly Limit Coverage of Medical Scans as Costs Increase

2007-03-21 20:49:41

Insurers Increasingly Limit Coverage of Medical Scans as Costs Increase
As diagnostic imaging, such as PET scans or MRIs, continues to grow in
popularity, insurers are looking to limit coverage of the costly scans, the
Baltimore Sun reports. Diagnostic imaging accounts for about $100 billion
annually, or about 5% of national health care spending. Medicare payments to
physicians for imaging had "by far the highest growth rate" of medical billing
categories examined in a 2000 to 2005 study by the CMS Office of the Actuary.
A 2004 study published in the journal Stroke found that the cost of medical
scans is offset by allowing physicians to make earlier diagnoses and getting a
patient to start treatment more quickly. In addition, improved imaging
technology "has vastly reduced the need for expensive exploratory or unneeded
surgery," according to the Sun. However, there also are instances "where
unneeded scans are ordered, or where a less costly alternative would have
sufficed," the Sun reports. There also is concern that many doctors are
overusing self-referrals to boost revenue.
Some insurers are paying lower rates for imaging services in an attempt to "rein
in costs," the Sun reports. Medicare this year instituted limits on certain fees
paid to doctors, which are expected to reduce the amount spent on imaging. Most
radiology benefit managers are trying to control costs through requiring
pre-authorization of scans. According to a November 2006 study published in the
Journal of the American College of Radiology, a requirement that doctors receive
pre-authorization for scans was found to decrease CT scans by a third and MRIs
by 9% during the two years that the requirement was instituted. However,
receiving authorization can be a "tedious" and time-consuming process, the Sun
reports (Salganik, Baltimore Sun, 5/13).
The JACR study is available online.
http://www.kaisernetwork.org/daily_reports/rep_index.cfm?DR_ID=44894

The Danger in Drug Kickbacks

2007-03-21 18:00:09

The Danger in Drug Kickbacks
The explosion in the use of three anti-anemia drugs to treat cancer and kidney
patients illustrates much that is wrong in the American pharmaceutical
marketplace. Thanks to big payoffs to doctors, and reckless promotional ads
permitted by lax regulators, the drugs have reached blockbuster status. Now we
learn that the dosage levels routinely injected or given intravenously in
doctors' offices and dialysis centers may be harmful to patients.
As Alex Berenson and Andrew Pollack laid bare in The Times on May 9, wide use of
the medicines - Aranesp and Epogen, from Amgen; and Procrit, from Johnson &
Johnson - has been propelled by the two companies paying out hundreds of
millions of dollars in so-called rebates. Doctors typically buy the drugs from
the companies, get reimbursed for much of the cost by Medicare and private
insurers, and on top of that get these rebates based on the amount they have
purchased.
Although many doctors complain that they barely break even or even lose money on
the costly drugs, for high-volume providers the profits can be substantial. One
group of six cancer doctors in the Pacific Northwest earned a profit of about
$1.8 million last year thanks to rebates from Amgen, while a large chain of
dialysis centers gets an estimated 25 percent of its revenue, and a higher
percentage of its profits, from the anemia drugs. It seems likely that these
financial incentives have led to wider use and the prescribing of higher doses
than medically desirable.
Although the drugs are deemed valuable in fighting severe anemia, there is scant
evidence they help much in moderate cases and some evidence that high doses can
be dangerous. Half of the dialysis patients in this country are now receiving
enough of the drugs to raise their red blood cell counts to levels deemed risky
by the Food and Drug Administration. And last week a panel of cancer experts
urged the F.D.A. to impose additional restrictions on use of the drugs in
patients receiving cancer chemotherapy, based on studies that the drugs might
make some cancers worse or hasten the deaths of patients.
Use of Procrit has also been fueled by television ads suggesting that it makes
elderly cancer patients more energetic and, pushing all the emotional buttons,
allows them to keep up with their grandchildren. That claim has not been
established to the F.D.A.'s satisfaction, and a top official said last week that
his agency owes the public a good explanation for why it allowed the ads to
continue.
With any luck, the advisory panel's concerns should cause many oncologists to
think twice before dispensing the anti-anemia drugs. But the surest way to slow
the overprescribing is to stop the rebates. Federal laws already bar drug
companies from paying doctors to prescribe medicines in pill form. That
prohibition should be extended to injected and intravenous medicines.
http://www.nytimes.com/2007/05/14/opinion/14mon1.html?_r=2&oref=slogin&oref=slog\
in

Allie needs help, liver transplant

2007-03-21 05:46:36

Allie needs help, liver transplant
By James Dimond, jdimond@...
Allie Brown and her family are racing against the clock to raise money so
she can receive an urgent liver transplant from a specialist in Chicago.
Doctors suspect the George Hicks High student has cirrhosis of the liver
and say she urgently needs treatment.
Allie's family would like to have their daughter on a plane to Chicago
next week but, having already spent more than $30,000 on tests and treatment,
they simply don't have the money.
In a bid to raise money for Allie's treatment, a fish fry will be held
this Saturday at Heritage Kitchen, West Bay, from 10am - 3pm.
Allie's condition first surfaced in May 2006.
Her mother, Joley Manderson, knew something was wrong when Allie, 12,
started to lose her appetite and complain of a pain under her arm.
Tests in May showed that Allie had Epstein Barr Virus, a mono-like
condition that drains the body of its energy.
From there her health started to deteriorate. Allie's weight plunged from
135 pounds to 78 pounds and her liver started to enlarge.
Allie spent time in George Town Hospital before being transferred to the
Baptist Hospital in Miami for a liver biopsy.
Since then, Allie has been sent back and forth between Miami and Grand
Cayman as doctors try to establish the cause of her illness.
Last week her case was referred to a liver and transplantation specialist
at Chicago's Children's Memorial Hospital.
After looking at Allie's files, he advised that cirrhosis of the liver
appeared to be the problem. The solution: a liver transplant in Chicago.
Though the illness has been hard, Mrs. Manderson says the family has drawn
inspiration from Allie's brave outlook and faith.
"Even though she knows she has this problem, she looks at it and thanks
God she is alive.
"Sometimes she says to me 'things like this happen so God can see how
strong we are and so he can see how much faith we have in him'."
To make things worse, Allie's sickness has prevented her from attending
school since October 2006.
Mrs. Manderson says her daughter needs a home tutor so she doesn't fall
any further behind in her learning.
Speaking on Wednesday, Mrs. Manderson said her family is grateful for the
generous support they had already received from the community.
She said she hopes Saturday's fish fry will net enough money to allow her
daughter to get on the plane to Chicago - and back to health - as soon as
possible.
For more information on Saturday's fish fry, or to donate money, call
Joley on 327-6705 or Gwenda on 924-2149.
http://www.caycompass.com/cgi-bin/CFPnews.cgi?ID=1022066

Editorials Address Pharmaceutical Industry

2007-03-21 03:27:23

Editorials Address Pharmaceutical Industry
Two newspapers recently published editorials related to prescription drugs.
Summaries appear below.
a.. New York Times: "The explosion in the use of three anti-anemia drugs to
treat cancer and kidney patients illustrates much that is wrong in the American
pharmaceutical marketplace," a Times editorial states. According to the Times,
sales of the drugs -- Aranesp and Epogen from Amgen and Procrit from Johnson &
Johnson -- have been "propelled by the two companies paying out hundreds of
millions of dollars in so-called rebates." The Times states, "It seems likely
that these financial incentives have led to wider use and the prescribing of
higher doses than medically desirable." According to the Times, the "surest way
to slow the overprescribing is to stop the rebates." The editorial concludes,
"Federal laws already bar drug companies from paying doctors to prescribe
medicines in pill form. That prohibition should be extended to injected and
intravenous medicines" (New York Times, 5/14).
b.. Washington Post: Legal settlements that allow brand-name pharmaceutical
companies to pay off generic drug makers to delay market introduction of generic
drugs "rob[s]" U.S. consumers of "potentially huge savings," a Post editorial
states. Sen. Herb Kohl (D-Wis.) and other lawmakers have introduced legislation
(S 316) to prohibit the practice, the editorial notes, adding that the bill is
"a long-overdue reform that Congress should pass soon, regardless of the
pharmaceutical industry's strong opposition." The editorial concludes,
"Otherwise, Americans will not benefit from the competitive generic drug
approval system that Congress tried to establish" (Washington Post, 5/13).
http://www.kaisernetwork.org/daily_reports/rep_index.cfm?DR_ID=44898

To Err is Human, to Disclose It to Patients Is Optional

2007-03-20 15:25:18

To Err is Human, to Disclose It to Patients Is Optional
By Neil Osterweil, Senior Associate Editor, MedPage Today
Reviewed by Robert Jasmer, MD; Associate Clinical Professor of Medicine,
University of California, San Francisco
May 11, 2007
IOWA CITY, Iowa, May 11 -- What physicians say about disclosing errors to
patients and what they actually do when they make an error may be two different
things, said investigators here.
In a survey of physician and trainee attitudes regarding disclosure of errors to
patients, more than 90% of faculty physicians and residents said they would
disclose errors resulting in either minor or major harm to patients, reported
Lauris Kaldjian, M.D., Ph.D. and colleagues from the University of Iowa and
other centers.
But reactions in real life seem to be different. Only 41% of respondents
confessed to disclosing an actual, albeit minor, medical error, and only 5% said
that they had told a patient about a major error resulting in disability or
death, the authors wrote in the online version of the Journal of General
Internal Medicine.
"Most doctors recognize that they're fallible, but they still strive for
perfection and, for the most part, hold each other accountable to a high
standard of practice that approximates perfection," said Dr. Kaldjian, director
of the Program in Biomedical Ethics and Medical Humanities at the Carver College
of Medicine.
"The idea persists that the physician rides into the clinic on the white horse,"
Dr. Kaldjian said. "To come in as the healer and then realize that you have
harmed is a difficult thing to accept, let alone admit."
He and his colleagues at Iowa, Yale, and Penn State conducted a survey of
faculty physicians, residents, and medical students at their respective centers.
They asked questions about minor errors, such as "Have you ever made a mistake
that prolonged treatment or caused discomfort and told the patient (or the
patient's family) that a mistake was made?" and major errors, such as "Have you
ever made a mistake that caused disability or death and told the patient (or the
patient's family) that a mistake was made?"
The survey participants were also presented with a hypothetical case in which a
physician fails to note a patient's allergy to cephalosporins and gives him one
of the drugs to treat pneumonia. They were then asked how they would respond to
each of three possible outcomes: no harm to the patient, minor harm (diffuse
itching and a rash) or major harm (respiratory distress, anaphylactic shock, and
myocardial infarction).
Study outcome measures were actual and hypothetical error disclosure, attitudes
toward disclosure, and demographic factors.
The authors received responses from 538 physicians, residents, and students for
a response rate of 77%.
When it came to the hypothetical situations, they found that faculty respondents
were more likely than either residents or students to disclose an error
resulting in no harm, with 80% of faculty, 63% of residents, and 50% of students
willing to 'fess up (P<0.001).
Nearly all respondents agreed that they would disclose errors causing minor harm
(99% of faculty, 95% of residents, and 93%, of students, P=0.06), and the vast
majority also said they would report the most egregious errors (97% of
physicians, 90% of residents, and 94%, of students, P=0.03).
The more senior physicians were less likely than either residents or students to
worry about malpractice litigation (76% vs 83% vs 91%, P<0.001), professional
discipline (46% vs 66% vs 86%, P<0.001), loss of reputation (54% vs 67% vs 76%,
P<0.001), or blame from colleagues (47% vs 62% vs 75%, P<0.001), the authors
found.
Faculty physicians were also less to agree that the decision to disclose
"depends on whether I think the information will help or harm the patient" (21%
vs 44% vs 52%, P<0.001) or to believe that disclosure would help alleviate their
guilt feelings (50% vs 69% vs 74%, P<0.001), the researchers wrote. Faculty and
residents were more likely than students to agree that error disclosure
"strengthens my patient's trust in me as a physician" (64% vs 65% vs 46%,
P<0.001).
Slightly less than half of all respondents (47%) acknowledged having made at
least one medical error, including 62% of faculty and 36% of residents. Of this
group, 46% acknowledged making a minor error, and 9% confessed to a major error.
But when it came to real-world disclosure of errors to patients, only 41% of
faculty and residents said they'd told a patient about an actual minor error and
only 5% had disclosed an actual major error.
On the other end of the spectrum, 19% said they had not disclosed an actual
minor error and 4% said they had failed to tell a patient about an actual major
error.
"There appears to be a gap between physicians' attitudes and practices regarding
error disclosure, " the authors wrote.
"Willingness to disclose errors was associated with higher training level and a
variety of patient-centered attitudes, and it was not lessened by previous
exposure to malpractice litigation."
Dr. Kaldjian said that while the survey data suggested that about half of the
respondents were infallible, "it seems fair to assume that all of us have made
at least a minor error, if not a major error, sometime in our careers."
The authors acknowledged that the self-report nature of the survey is subject to
"social desirability" bias-that is, the tendency of respondents to put
themselves or the profession in a more favorable light, despite the anonymous
design of the survey).
"Under the right circumstances, physicians should be able to act with courage
and compassion to communicate clearly with patients and families about errors,"
they wrote. "Creating such circumstances requires concerted efforts to build a
culture of learning and healing that supports the physician's self-identity as a
healer, at a time when it may be threatened, and promotes the dignity and well
being of the patient after he or she has been harmed."
The authors also acknowledged that the study was cross-sectional and could
therefore not account for changes over time or differences between the
participating centers. They also pointed out that the survey was limited to
faculty, residents and students in teaching hospitals and represented only
internal medicine, family medicine, and pediatrics, so the results may not be
generalizable to physicians in other specialties or practice types.
The study was funded by the Robert Wood Johnson Foundation's Generalist
Physician Faculty Scholars Program. The authors had no conflict-of-interest
disclosures.
Action Points
a.. Explain to patients who ask that policies governing physician disclosure
to patients of medical errors vary from one institution to the next
http://www.medpagetoday.com/PublicHealthPolicy/PracticeManagement/dh/5631

Motherhood is reward times 4

2007-03-20 10:28:32

Motherhood is reward times 4
Despite premature births and wait for a transplant call
By Jewell Cardwell
Jodi Del Ferraro has the uncanny ability to smile and not be weary, even when
everything around her seems to be crashing down.
Nowhere is that more evident than in the way the Akron woman cares for her
children: 4-year-old daughter Michela, and 11-month-old triplet sons Mason,
Parker and Chase.
All were born prematurely. All had low birth weights. Two of the triplets have a
host of health problems.
Mason, who was born with two brain bleeds, is showing signs of cerebral palsy
and he has apnea, a cessation of breathing during sleep.
Chase -- the sickest -- is awaiting a donor for a liver transplant. His stunted
growth, distended tummy and yellowed complexion speak volumes about the urgency.
So, Jodi and Michael, her husband of almost seven years, have their hands full
-- praying, walking the floors, ferrying their infants back and forth from
doctors' appointments and hospitals, doing their own exercise and therapy with
Mason, and battling with health insurance.
A never-ending job
``Motherhood is so much harder than when I was working 9 to 5. It never ends,''
said Jodi, who spent nine years as a social worker for Community Support
Services. ``But I love it. Motherhood is definitely the most rewarding job I
ever could hope to have.''
Added Michael: ``She's a great mom. She's definitely dedicated to this family.''
That's what allows her to take with such grace the bitter with the sweet.
Here's part of the couple's back story:
When Michela was born at 24 weeks, she weighed only 1 pound, 2 ounces. ``Doctors
suggested not resuscitating her if I went into labor in 23 weeks,'' Jodi said,
returning to thoughts of the not-so-distant past.
Amazingly, Michela -- born at Akron City Hospital -- arrived one hour into her
24th week. Apart from having a severe aversion to eating, which required tube
feeding for the first 18 months of her life, she has been unusually healthy.
Daughter is healthy
``She went from tube feeding straight to the Sippy cup,'' her mother joked.
Proof of just how well Michela -- nicknamed ``The Hurricane'' -- is doing could
be captured in the way she stormed the room with an impish smile while doing
somersaults.
Jodi's sons' were delivered at City Hospital by C-section at 29 weeks after
months of mandatory bed rest for Mom.
Baby A (Mason) weighed 3 pounds, 1 ounce; Baby B (Chase), 2 pounds, 9 ounces;
and Baby C (Parker), 3 pounds, 2 ounces.
So the Del Ferraros are no strangers to Akron Children's Hospital's neonatal
intensive care unit (NICU) or to the good works of the March of Dimes, which
raises money to fight birth defects.
In fact, the importance of both prompted the Del Ferraros and other family
members, calling themselves the ``Born to Be Wild'' team, to turn out Saturday
for the March of Dimes Walk-America event at Canal Park and the NICU's big
reunion party.
Michael Del Ferraro makes his living overseeing the drivers at Cornerstone
Medical Services. But he's earning his wings as a NICU parent mentor, helping
other parents who are new on their journey of uncertainty.
Part of his wife's juggling act includes regularly shuttling Chase to medical
appointments at Cincinnati Children's Hospital, where the liver transplant is to
take place.
The fragile infant was just released days ago from his most recent stay at Akron
Children's Hospital.
Through it all, the Del Ferraros -- by leaning on their faith, family and
friends -- are somehow rising to all that's being asked of them.
Lately, that's been quite a lot.
You need only read the online journal that the irrepressible Jodi writes and
posts daily to get a window on that.
``The journal helps with my sanity,'' Jodi said matter-of-factly.
It's a much-welcomed bromide for others, too.
``We were just getting so many calls about the babies,'' Jodi said ``We have a
lot of family and friends who are out of town that it just made sense.''
Jodi, who began the journaling before the triplets were born, even posts
photograghs. ``I wish I had done this with Michela,'' she lamented.
The Web site --
http://www.parentshack.com/site/index.jsp?sn=DelFerraro&bid=19805 -- is so
popular with those following Chase's journey that if Jodi misses a day, she
hears from concerned folks asking for an update.
Web site gets visitors
And there's this:
``One month we got 9,000 hits,'' Michael marveled. ``It's been neat to see
entries from people we don't even know.''
No strangers to the Internet, the Del Ferraros say they met and fell in love
online.
Jodi's down-the-road goal ``after everything is settled down'' is to become a
major advocate for organ donation. Actually, she's already doing some of that in
her journaling.
``I can't believe how many people haven't signed up to be organ donors and the
ignorant reasons they have for not doing so,'' she said. ``They say things like,
`I don't want to be chopped up for my funeral.' ''
But that's talk for another day.
For now, this mother's focus is on tiny Chase.
She's knows the call from the transplant team telling them that a liver has been
found could come at any time. And as much as she wants that pager to go off,
Jodi Del Ferraro's prayer is that it doesn't come today -- Mother's Day.
``Not Mother's Day. I couldn't imagine how the other family, that other mother,
would feel losing a child on Mother's Day,'' she said softly as she cuddled
Chase in her arms.
``I think that would be too much!''

Hepatitis C epidemic in New York?

2007-03-20 09:52:53

Hepatitis C epidemic in New York?
By Dr. Jay Adlersberg
(New York-WABC, May 11, 2007) - Medical experts are calling it an epidemic
across New York. The number of Hepatitis C cases have doubled in the past five
years.
With what you can do to protect yourself, Seven's On Call with Dr. Jay
Adlersberg.
Hepatitis C is the most common liver problem in the Hispanic-American community.
It's only more common in Native Americans.
Debbie Delgado-Vega has had two liver transplants. When she realized how little
other Hispanic-Americans knew about liver disease, she started LOLA, the Latino
Organization for Liver Awareness.
"I thought, maybe I need to create an organization that would educate the
Hispanic community about liver disease in a language they can understand," she
said.
Infection with the Hepatitis C virus is the major liver problem for Latinos,
perhaps because the illness is very common in the Spanish-speaking Caribbean.
Liver transplant is the only treatment for the scarring and liver cancer that
can result from Hepatitis C.
"There's a critical donor shortage," said Dr. Lewis Teperman, of the NYU Medical
Center. "There are 17,000 people on the list as we speak, and we do, if we're
lucky, 7,000 a year. The number one reason for liver transplants is the U.S. is
Hepatitis C."
Risk factors for Hepatitis C are getting a blood transfusion before 1992, when a
test for the virus came out; having HIV/AIDS; having tattoos or body piercings;
and sharing a tooth brush or razor.
Possible risk factors include getting a manicure, using nasal cocaine and being
employed as a health care worker.
Hepatitis B is another serious type of liver infections, but 95 percent of
patients get over it without a problem. But with Hepatits C, the majority of
patients develop an infection that does not go away.
LOLA has helped 50,000 of these patients find support and treatment. It's
Debbie's way of giving thanks for her life.
"My only way to give back or just to continue living is by helping others to
live as well," she said. "Isn't that what it's all about?"
And it's not just the Hispanic community. Anyone can be infected with the
Hepatitis C virus. LOLA is bilingual and offers support to anyone wanting
information about the illness and liver disease in general.
http://abclocal.go.com/wabc/story?section=health&id=5296756

Hepatitis C Is Silent Epidemic In Maryland

2007-03-20 02:26:39

Hepatitis C Is Silent Epidemic In Maryland
Hepatitis C
An estimated 100,000 Marylanders are infected with hepatitis C virus (HCV) and
nearly two-thirds of them don't know it.
"Complications of HCV infection are a serious health burden in our State," said
Michelle Gourdine, M.D., DHMH Deputy Health Secretary for Public Health
Services. "That's why DHMH is working to help all Marylanders be more aware of
this important public health problem."
Nine out of 10 people with HCV infection have no symptoms in the early stages of
the disease. In fact, serious symptoms may appear 20 - 30 years after infection
and by then, the liver may have been badly damaged. Testing for HCV infection
involves only a blood test and usually can detect the infection within months
after it starts, long before serious liver injury occurs.
"There is no vaccination to protect against HCV", said Dr. Gourdine. "But there
are ways to protect your liver and avoid transmitting HCV. If you're at risk, a
simple blood test is a good way to know your status."
HCV infection is four times more prevalent than HIV infection and the most
common blood borne infection in the United States. It's the leading cause of
liver disease and the number one indication for liver transplants.
http://www.emaxhealth.com/39/11992.html

Vermonters urged to get tested for hepatitis C

2007-03-19 13:33:34

Vermonters urged to get tested for hepatitis C
May 12, 2007
By Mel Huff Times Argus Staff
BURLINGTON - The Vermont Department of Health is urging people most likely
to have been exposed to hepatitis C to get tested for the disease.
"Hepatitis C is a silent infection," said Patsy Tassler, a Department of
Health epidemiologist. People can be unaware that they harbor the hepatitis C
virus until it starts causing liver disease and other problems.
In Vermont, 61 percent of cases of hepatitis C are found in men and 57
percent are seen in people over 40. People can be infected for decades before
having symptoms.
"Lots of people who don't consider themselves at high risk are infected,"
Tassler said. "If you have any risk factors, even decades in the past, you
should ask for a test and know your status. There are preventive actions to
protect your liver and prevent spreading the infection."
Hepatitis C, a potentially fatal liver disease, is among the most common
blood-borne illnesses. In Vermont, it is the second most commonly reported
communicable disease: In 2006, there were nearly 900 newly identified cases.
Based on national statistics, as many as 12,000 Vermonters have hepatitis C, the
health department stated.
In a recent article in the Journal of the American Medical Association,
researchers reported that hepatitis C infection was associated with a 20 percent
to 30 percent greater risk of non-Hodgkin lymphoma, a lymph tissue cancer. They
also found that the hepatitis C virus was more than three times as common in
U.S. veterans who used the Veterans Affairs health care system as in the general
population: 5 percent of those veterans were infected with the virus.
The study, which involved hundreds of thousands of veterans cared for at
VA facilities between 1997 and 2004, was carried out by Dr. Thomas P. Giordano
and colleagues at Baylor College of Medicine and the Michael E. DeBakey Veterans
Affairs Medical Center in Houston. Risk factors for hepatitis C include:
a.. Using needles, syringes and other "works" that have been used by other
people and may have infected blood on them. (Even injecting drugs one time
decades in the past can result in infection, Tassler said.)
a.. Having received a blood transfusion, a blood product like plasma or a
solid organ transplant before July 1992 from a donor whose blood was infected
with hepatitis C. (Since July 1992, the blood supply has been screened, Tassler
noted.)
a.. Receiving long-term kidney dialysis. (The number of times you go
through dialysis increases the possibility that you've come in contact with
something that is contaminated, Tassler explained.)
a.. For health care workers, frequently contacting blood on the job,
especially through accidental needle sticks.
In March, the health department started a new program that offers free and
anonymous hepatitis C testing at the syringe-exchange programs in Burlington,
St. Johnsbury and White River Junction.
People can also ask their health care provider for a test, Tassler said.
Medicaid and VHAP cover hepatitis C antibody and viral testing. Medicare does
not pre-approve testing but reviews requests for payment and covers it if it is
"medically necessary."
If providers request the test because they believe a patient is at risk
for the hepatitis C infection, the test would be considered medically necessary,
according to the health department.
http://www.timesargus.com/apps/pbcs.dll/article?AID=/20070512/NEWS02/705120352/1\
003/NEWS02

Hep C Walk in NYC on May 15 with Chris Lawford and LOLA

2007-03-19 10:24:04